Acrivon AB
559152-0944ActiveDeveloping targeted cancer therapies using proprietary proteomics platform.
Overview
- 10–19
- Employees
- 20–50M SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Peter Blume-Jensen
CEO, President, Founder Chairperson
Tiffany Crowell
Head of Clinical Operations
David Proia
Head of Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
+24 more contacts in Funnelfeedr
Description
Acrivon Therapeutics is a clinical-stage oncology company focused on developing targeted therapies to improve patient lives. They utilize their proprietary Acrivon Predictive Precision Proteomics (AP3) platform, which moves beyond traditional genomics. This platform generates unique OncoSignature co...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559152094401
Decision Makers
28 contacts in FunnelfeedrPeter Blume-Jensen
CEO, President, Founder Chairperson
Tiffany Crowell
Head of Clinical Operations
David Proia
Head of Biology and Drug Discovery
Eric Devroe
Chief Operating Officer
Ivana Magovčević-Liebisch
Director
Charles (Chuck) Baum
Director
Katharine Peterson
Head of Finance & Accounting
John van Duzer
Head of Chemistry Manufacturing and Controls
Mansoor Raza Mirza
Chief Medical Officer
Joon Jung
Head of Data Science
Mary-Alice Miller
Chief Legal Officer
Michail Shipitsin
Head of Biomarker Development
Adam D. Levy
Chief Financial Officer
Derek DiRocco
Director
Praveen Marapaka
SVP, Global Regulatory Affairs
Jesper Olsen
Academic Co-Founder, Head of Phosphoproteomics
Kristina Masson
Co-Founder, EVP, Business Operations, Site Head, Director
Monica Phadnis
SVP, Clinical Operations
Sharon Shacham
Director
Christina Scherer
Head of Early Program Management
Thomas P. Nifong
Head of Clinical CDx Operations
Erick Gamelin
Chief Development Officer
Santhosh Palani
Director
Michael Tomsicek
Director
Virna Schuck
VP of Clinical Pharmacology
Sam Rua
Head of CDx Regulatory
Rajshree Kandadai
Head of Business Development
Bruce Close
Head of Quality and Compliance
Similar Companies
20 similar companies in FunnelfeedrAkiram Therapeutics AB
1–4 employeesPioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
MyCural Therapeutics AB
10–19 employeesDeveloping novel small molecule therapies targeting the MYC oncoprotein.
APIM THERAPEUTICS AS
Biotech company developing novel peptide therapeutics targeting cancer cell survival mechanisms.
Biovica International AB
10–19 employeesDeveloping blood tests to monitor cancer treatment efficacy.
Biovica Services AB
Developing blood tests to monitor cancer treatment efficacy.
Browse More
Acrivon AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo